AlphaCore Capital’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $105K | Buy |
826
+223
| +37% | +$28.2K | ﹤0.01% | 672 |
|
|
2025
Q1 | $77.2K | Hold |
603
| – | – | 0.01% | 530 |
|
|
2024
Q4 | $79.7K | Hold |
603
| – | – | 0.02% | 206 |
|
|
2024
Q3 | $87.7K | Buy |
603
+1
| +0.2% | +$146 | 0.02% | 201 |
|
|
2024
Q2 | $82.6K | Hold |
602
| – | – | 0.02% | 189 |
|
|
2024
Q1 | $82.6K | Sell |
602
-302
| -33% | -$41.4K | 0.02% | 155 |
|
|
2023
Q4 | $123K | Buy |
904
+304
| +51% | +$41.3K | 0.02% | 238 |
|
|
2023
Q3 | $73.4K | Hold |
600
| – | – | 0.01% | 256 |
|
|
2023
Q2 | $76.2K | Hold |
600
| – | – | 0.01% | 230 |
|
|
2023
Q1 | $77.5K | Hold |
600
| – | – | 0.02% | 158 |
|
|
2022
Q4 | $78.7K | Buy |
600
+2
| +0.3% | +$262 | 0.03% | 98 |
|
|
2022
Q3 | $70K | Buy |
598
+9
| +2% | +$1.05K | 0.03% | 80 |
|
|
2022
Q2 | $69K | Hold |
589
| – | – | 0.03% | 93 |
|
|
2022
Q1 | $77K | Hold |
589
| – | – | 0.03% | 90 |
|
|
2021
Q4 | $90K | Buy |
589
+1
| +0.2% | +$153 | 0.04% | 61 |
|
|
2021
Q3 | $95K | Hold |
588
| – | – | 0.05% | 66 |
|
|
2021
Q2 | $96K | Buy |
588
+1
| +0.2% | +$163 | 0.05% | 49 |
|
|
2021
Q1 | $88K | Sell |
587
-176
| -23% | -$26.4K | 0.06% | 36 |
|
|
2020
Q4 | $116K | Hold |
763
| – | – | 0.09% | 37 |
|
|
2020
Q3 | $103K | Hold |
763
| – | – | 0.09% | 37 |
|
|
2020
Q2 | $104K | Buy |
763
+2
| +0.3% | +$273 | 0.1% | 38 |
|
|
2020
Q1 | $82K | Hold |
761
| – | – | 0.06% | 83 |
|
|
2019
Q4 | $92K | Buy |
+761
| New | +$92K | 0.06% | 81 |
|